The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Epithelial Cell Responses to Infection with Human Papillomavirus
Open accessAbstract
SUMMARY: Human papillomavirus (HPV) infection of the genital tract is common in young sexually active individuals, the majority of whom clear the infection without overt clinical disease. Most of those who do develop benign lesions eventually mount an effective cell-mediated immune (CMI) response, and the lesions regress. Regression of anogenital warts is accompanied histologically by a CD4 + T cell-dominated Th1 response; animal models support this and provide evidence that the response is modulated by antigen-specific CD4 + T cell-dependent mechanisms. Failure to develop an effective CMI response to clear or control infection results in persistent infection and, in the case of the oncogenic HPVs, an increased probability of progression to high-grade intraepithelial neoplasia and invasive carcinoma. Effective evasion of innate immune recognition seems to be the hallmark of HPV infections. The viral infectious cycle is exclusively intraepithelial: there is no viremia and no virus-induced cytolysis or cell death, and viral replication and release are not associated with inflammation. HPV globally downregulates the innate immune signaling pathways in the infected keratinocyte. Proinflammatory cytokines, particularly the type I interferons, are not released, and the signals for Langerhans cell (LC) activation and migration, together with recruitment of stromal dendritic cells and macrophages, are either not present or inadequate. This immune ignorance results in chronic infections that persist over weeks and months. Progression to high-grade intraepithelial neoplasia with concomitant upregulation of the E6 and E7 oncoproteins is associated with further deregulation of immunologically relevant molecules, particularly chemotactic chemokines and their receptors, on keratinocytes and endothelial cells of the underlying microvasculature, limiting or preventing the ingress of cytotoxic effectors into the lesions. Recent evidence suggests that HPV infection of basal keratinocytes requires epithelial wounding followed by the reepithelization of wound healing. The wound exudate that results provides a mechanistic explanation for the protection offered by serum neutralizing antibody generated by HPV L1 virus-like particle (VLP) vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434 · cited 1×
“Eukaryotic cells express germ line-encoded receptors of the innate immune system, pathogen recognition receptors (PRRs), that recognize invariant molecular motifs known as pathogen-associated molecular patterns (PAMPs) (46).”
BackgroundQuadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Bernard, H.-U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., & de Villiers, E.-M. (2010) · Virology · doi:10.1016/j.virol.2010.02.002 · Cited by 1,669
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Skin immune sentinels in health and disease
Nestle, F. O., Di Meglio, P., Qin, J.-Z., & Nickoloff, B. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2622 · Cited by 1,420
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Doorbar, J. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.006 · Cited by 856
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells
Merad, M., Ginhoux, F., & Collin, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2455 · Cited by 850 · cited 1×
“CD8 cells (47), but recent data from the mouse suggest that in”
BackgroundBosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells
Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R. S., Wojtasiak, M., Shortman, K., Carbone, F. R., et al. (2009) · Nature Immunology · doi:10.1038/ni.1724 · Cited by 715
Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., & Schlegel, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 668
Harro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., & Lowy, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 589
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Self-citationLinks between innate and adaptive immunity via type I interferon
Le Bon, A., & Tough, D. F. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00354-0 · Cited by 582
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Lacey, C. J. N., Lowndes, C. M., & Shah, K. V. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.015 · Cited by 535
Roberts, J. N., Buck, C. B., Thompson, C. D., Kines, R., Bernardo, M., Choyke, P. L., Lowy, D. R., & Schiller, J. T. (2007) · Nature Medicine · doi:10.1038/nm1598 · Cited by 503
Immunological Events in Regressing Genital Warts
Coleman, N., Birley, H. D. L., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D., & Stanley, M. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.768 · Cited by 479
Self-citationChapter 5: Updating the natural history of HPV and anogenital cancer
Moscicki, A.-B., Schiffman, M., Kjaer, S., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.018 · Cited by 478
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
The FUTURE I/II Study Group (2010) · BMJ · doi:10.1136/bmj.c3493 · Cited by 415
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
Stanley, M. A. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01151.x · Cited by 377
Self-citationType-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions
Vinokurova, S., Wentzensen, N., Kraus, I., Klaes, R., Driesch, C., Melsheimer, P., Kisseljov, F., Dürst, M., Schneider, A., & von Knebel Doeberitz, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2754 · Cited by 370
Wentzensen, N., Vinokurova, S., & Doeberitz, M. V. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0009 · Cited by 368
Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S.-K., Kuypers, J., Kiviat, N., & Galloway, D. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.927 · Cited by 326
Kines, R. C., Thompson, C. D., Lowy, D. R., Schiller, J. T., & Day, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908502106 · Cited by 293
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
Park, J.-S., Kim, E.-J., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S.-J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 285
Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis.
Jabłońska, S., Dabrowski, J., & Jakubowicz, K. (1972) · PubMed · Cited by 241
Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Kanodia, S., Fahey, L., & Kast, W. M. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006869 · Cited by 241
Welters, M. J. P., de Jong, A., van den Eeden, S. J. F., van der Hulst, J. M., Kwappenberg, K. M. C., Hassane, S., Franken, K. L. M. C., Drijfhout, J. W., Fleuren, G. J., Kenter, G. G., et al. (2003) · PubMed · Cited by 213
The natural history of human papillomavirus infections of the mucosal epithelia
CHOW, L. T., BROKER, T. R., & STEINBERG, B. M. (2010) · APMIS · doi:10.1111/j.1600-0463.2010.02625.x · Cited by 206
Pett, M. R., Alazawi, W. O. F., Roberts, I., Dowen, S., Smith, D. I., Stanley, M. A., & Coleman, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3214 · Cited by 204
Self-citationDay, P. M., Gambhira, R., Roden, R. B. S., Lowy, D. R., & Schiller, J. T. (2008) · Journal of Virology · doi:10.1128/jvi.00143-08 · Cited by 183
Kalali, B. N., Köllisch, G., Mages, J., Müller, T., Bauer, S., Wagner, H., Ring, J., Lang, R., Mempel, M., & Ollert, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2694 · Cited by 179
Safaeian, M., Porras, C., Schiffman, M., Rodriguez, A. C., Wacholder, S., Gonzalez, P., Quint, W., van Doorn, L.-J., Sherman, M. E., Xhenseval, V., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq384 · Cited by 173
In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
Day, P. M., Kines, R. C., Thompson, C. D., Jagu, S., Roden, R. B., Lowy, D. R., & Schiller, J. T. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.003 · Cited by 171
Sapp, M. J., & Bienkowska‐Haba, M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07400.x · Cited by 161
Karim, R., Meyers, C., Backendorf, C., Ludigs, K., Offringa, R., van Ommen, G.-J. B., Melief, C. J. M., van der Burg, S. H., & Boer, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017848 · Cited by 158
Papillomavirus Life Cycle Organization and Biomarker Selection
Doorbar, J. (2007) · Disease Markers · doi:10.1155/2007/613150 · Cited by 158
Pett, M. R., Herdman, M. T., Palmer, R. D., Yeo, G. S. H., Shivji, M. K. K., Stanley, M., & Coleman, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600078103 · Cited by 157
Self-citationFrequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
de Jong, A., van der Burg, S. H., Kwappenberg, K. M. C., van der Hulst, J. M., Franken, K. L. M. C., Geluk, A., van Meijgaarden, K. E., Drijfhout, J. W., Kenter, G. G., Vermeij, P., et al. (2002) · PubMed · Cited by 156
Pattern Recognition via the Toll-Like Receptor System in the Human Female Genital Tract
Nasu, K., & Narahara, H. (2010) · Mediators of Inflammation · doi:10.1155/2010/976024 · Cited by 146
Black, A. P., Ardern‐Jones, M. R., Kasprowicz, V. O., Bowness, P., Jones, L., Bailey, A. S., & Ogg, G. S. (2007) · European Journal of Immunology · doi:10.1002/eji.200636915 · Cited by 145
Trimble, C. L., Clark, R. A., Thoburn, C. J., Hanson, N. C., Tassello, J., Frosina, D., Kos, F. J., Teague, J. E., Jiang, Y., Barat, N. C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002756 · Cited by 141
Regression of Canine Oral Papillomas Is Associated with Infiltration of CD4+ and CD8+ Lymphocytes
Nicholls, P. K., Moore, P. F., Anderson, D. M., Moore, R. A., Parry, N. R., Gough, G. W., & Stanley, M. (2001) · Virology · doi:10.1006/viro.2000.0789 · Cited by 140
Self-citationEvolving immunosuppressive microenvironment during human cervical carcinogenesis
Kobayashi, A., Weinberg, V, Darragh, T., & Smith-McCune, K. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.33 · Cited by 136
Day, P. M., Thompson, C. D., Buck, C. B., Pang, Y.-Y. S., Lowy, D. R., & Schiller, J. T. (2007) · Journal of Virology · doi:10.1128/jvi.00552-07 · Cited by 131
Papillomavirus infections and human genital cancer
Hausen, H. Z., de Villiers, E., & Gissmann, L. (1981) · Gynecologic Oncology · doi:10.1016/0090-8258(81)90067-6 · Cited by 129
Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo
Um, S., Rhyu, J.-W., Kim, E.-J., Jeon, K.-C., Hwang, E.-S., & Park, J. S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00871-0 · Cited by 126
Kobayashi, A., Greenblatt, R. M., Anastos, K., Minkoff, H., Massad, L. S., Young, M., Levine, A. M., Darragh, T. M., WEINBERG, V. K., & Smith‐McCune, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1091 · Cited by 126
Herdman, M. T., Pett, M. R., Roberts, I., Alazawi, W., Teschendorff, A. E., Zhang, X.-Y., Stanley, M., & Coleman, N. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl172 · Cited by 118
Self-citationWoo, Y. L., van den Hende, M., Sterling, J. C., Coleman, N., Crawford, R., Kwappenberg, K. M. C., Stanley, M., & van der Burg, S. H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24804 · Cited by 117
Self-citationHuman Keratinocyte Toll-like Receptors Promote Distinct Immune Responses
Miller, L. S., & Modlin, R. L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700559 · Cited by 107
Alazawi, W., Pett, M. R., Arch, B. N., Scott, L., Freeman, T. C., Stanley, M., & Coleman, N. (2002) · PubMed · Cited by 105
Self-citationFausch, S. C., Da Silva, D. M., Rudolf, M. P., & Kast, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3242 · Cited by 104
Nicholls, P. K., Klaunberg, B. A., Moore, R. A., Santos, E. B., Parry, N. R., Gough, G. W., & Stanley, M. (1999) · Virology · doi:10.1006/viro.1999.0060 · Cited by 97
Self-citationThe role of furin in papillomavirus infection
Day, P. M., & Schiller, J. T. (2009) · Future Microbiology · doi:10.2217/fmb.09.86 · Cited by 96
Gray, E. H., Pett, M. R., Ward, D. M., Winder, D. M., Stanley, M., Roberts, I., Scarpini, C. G., & Coleman, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3335 · Cited by 96
Self-citationGhim, S., Newsome, J., Bell, J. A., Sundberg, J. P., Schlegel, R., & Jenson, A. B. (2000) · Experimental and Molecular Pathology · doi:10.1006/exmp.1999.2298 · Cited by 81
Orth, G., Jablonska, S., Breitburd, F., Fãvre, M., & Croissant, O. (2013) · American Academy of Pediatrics eBooks · doi:10.1542/9781581107951-ch90 · Cited by 77
Woo, Y. L., Sterling, J. C., Damay, I., Coleman, N., Crawford, R., van der Burg, S., & Stanley, M. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01936.x · Cited by 73
Self-citationZhao, K., Gu, W., Fang, N. X., Saunders, N. A., & Frazer, I. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8643-8655.2005 · Cited by 64
Cell-mediated immune responses to COPV early proteins
Jain, S., Moore, R. A., Anderson, D. M., Gough, G. W., & Stanley, M. (2006) · Virology · doi:10.1016/j.virol.2006.07.032 · Cited by 37
Self-citationMyers, S. R., Leigh, I. M., & Navsaria, H. A. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00297.x · Cited by 29
Unger, E. R., & Duarte‐Franco, E. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70227-8 · Cited by 24
Yang, R., Murillo, F., Lin, K.-Y., Yutzy, W. H., Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., & Roden, R. B. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2624 · Cited by 20
Immunophenotyping of Skin Cells during Healing of Suction Blister Injury
Reusch, M., Mansbridge, J. N., Nickoloff, B. J., et al. (2009) · Dermatologica · doi:10.1159/000247665 · Cited by 18
Cited by
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Self-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationHuman papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
Infection in Organ Transplantation
Fishman, J. A. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14208 · Cited by 809
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
Metadata
- Authors
- Stanley, M. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2012-04
- Volume
- 25
- Issue
- 2
- Pages
- 215-222
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2097555726
- Cited by
- 473
- References
- 75
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.